Last reviewed · How we verify
NCT06746948
Dyadic Psychological Stress Among Lung Cancer Patient-caregiver Dyads
trial testing dyadic psychological distress in Lung Cancers in 254 participants. Completed in 31 December 2021.
30 June 2021
Quick facts
| Lead sponsor | Central South University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 254 |
| Start date | 1 January 2021 |
| Primary completion | 30 June 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- dyadic psychological distress
Conditions studied
- Lung Cancers — all drugs for Lung Cancers →
- Lung Cancer Patients — all drugs for Lung Cancer Patients →
Sponsor
Central South University
Who can join
18 and older, any sex, with Lung Cancers or Lung Cancer Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A lung cancer diagnosis has a huge impact on the psychological well-being of both patients and family caregivers. However, the current psychological stress status among dyads remains unclear. The investigators aimed to determine the prevalence of anxiety and depression and identify the factors that influence patients with lung cancer and their caregivers. The investigators will conduct a cross-sectional study of 254 dyads of lung cancer patients and family caregivers from four tertiary hospitals in Hunan Province, China from January 2021 to June 2021. Besides, the investigators used several instruments to collect data on depression, anxiety, illness perception, mindfulness, self-compassion, and dyadic coping. The independent samples t-test, analysis of one-way variance, Spearman's correlation analysis, and multiple linear regression analysis were employed. The results will recommend oncology nurses promptly screen high-risk patient-caregiver dyads who may suffer from severe psychological stress and provide them with targeted psychosocial interventions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevalence and influencing factors of the dyadic psychological stress among patients with lung cancer and their family caregivers: a cross-sectional study.
Li J, Li C, Zou J, Cheng FQ, et al · · 2025 · cited 3× · PMID 39762831 · DOI 10.1186/s12912-024-02635-z
Verify or expand the search:
- PubMed search for NCT06746948
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Cancers
Currently open trials in the same condition.
- NCT06926075 — Early Phase Study of KESONOTIDE™in Participants With Solid Tumours · Phase 1, PHASE2 · recruiting
- NCT06794125 — An Evaluation of Dose-escalation for Intrathoracic Tumours · NA · recruiting
- NCT07057648 — Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea · recruiting
- NCT06926140 — Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer · NA · recruiting
- NCT07064395 — Bright Light Therapy on Sleep Health in Lung Cancer Patients · NA · recruiting
Other Central South University trials
Trials by the same sponsor.
- NCT07444463 — Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications · NA · not yet recruiting
- NCT07446478 — TIS for Improving Cognitive Impairment Associated With Schizophrenia · NA · not yet recruiting
- NCT07045142 — Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients · Phase 3 · recruiting
- NCT07066813 — Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces · recruiting
- NCT07063901 — Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06746948 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central South University
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06746948.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing